These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17704294

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
    Alfano M, Sidenius N, Panzeri B, Blasi F, Poli G.
    Proc Natl Acad Sci U S A; 2002 Jun 25; 99(13):8862-7. PubMed ID: 12084931
    [Abstract] [Full Text] [Related]

  • 3. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD, Kanse SM, Deutsch V, Schmidt T, Eldor A, Preissner KT.
    Thromb Haemost; 1997 Mar 25; 77(3):540-7. PubMed ID: 9066008
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
    Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT.
    J Cell Sci; 2004 Jan 26; 117(Pt 3):477-85. PubMed ID: 14679304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT.
    Exp Cell Res; 1996 May 01; 224(2):344-53. PubMed ID: 8612711
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L, Fortunato O, Adduce L, Rizzi C, Hering J, Rovere-Querini P, Bianchi ME, Alfano M, Poli G.
    AIDS; 2009 Mar 13; 23(5):567-77. PubMed ID: 19194273
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR, Church FC.
    Int J Oncol; 2005 Sep 13; 27(3):749-57. PubMed ID: 16077925
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE, Saunders DN, Ranson M.
    Breast Cancer Res; 2007 Sep 13; 9(1):R14. PubMed ID: 17257442
    [Abstract] [Full Text] [Related]

  • 14. Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.
    Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P.
    J Neuroimmunol; 2004 Dec 13; 157(1-2):133-9. PubMed ID: 15579290
    [Abstract] [Full Text] [Related]

  • 15. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM, Johns A, Morser J, Dole WP, Greaves DR, Deng GG.
    J Cell Physiol; 2005 Jul 13; 204(1):73-82. PubMed ID: 15573379
    [Abstract] [Full Text] [Related]

  • 16. Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.
    Graziano F, Elia C, Laudanna C, Poli G, Alfano M.
    PLoS One; 2011 Jul 13; 6(8):e23674. PubMed ID: 21858203
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U, Magdolen V, Hapke S, Schmitt M.
    Biol Chem; 2003 Aug 13; 384(8):1119-31. PubMed ID: 12974381
    [Abstract] [Full Text] [Related]

  • 20. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.
    Chavakis T, Kanse SM, Yutzy B, Lijnen HR, Preissner KT.
    Blood; 1998 Apr 01; 91(7):2305-12. PubMed ID: 9516128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.